Amphastar P (NASDAQ:AMPH) — Market Cap & Net Worth
Market Cap & Net Worth: Amphastar P (AMPH)
Amphastar P (NASDAQ:AMPH) has a market capitalization of $854.96 Million ($854.96 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9778 globally and #2622 in its home market, demonstrating a 2.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amphastar P's stock price $19.96 by its total outstanding shares 44092919 (44.09 Million). Review Amphastar P balance sheet liabilities to assess the company's total debt and financial obligations.
Amphastar P Market Cap History: 2015 to 2026
Amphastar P's market capitalization history from 2015 to 2026. Data shows growth from $627.44 Million to $880.09 Million (4.71% CAGR).
Index Memberships
Amphastar P is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.04% | #266 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #1005 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.70 Trillion | 0.05% | #152 of 263 |
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.08% | #497 of 602 |
Weight: Amphastar P's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Amphastar P Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amphastar P's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.64x
Amphastar P's market cap is 1.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
12.04x
Amphastar P's market cap is 12.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $812.19 Million | $255.16 Million | $10.53 Million | 3.18x | 77.12x |
| 2017 | $848.35 Million | $240.18 Million | $4.51 Million | 3.53x | 188.19x |
| 2018 | $877.45 Million | $294.67 Million | -$5.74 Million | 2.98x | N/A |
| 2019 | $850.55 Million | $322.36 Million | $48.94 Million | 2.64x | 17.38x |
| 2020 | $886.71 Million | $349.85 Million | $1.40 Million | 2.53x | 632.01x |
| 2021 | $1.03 Billion | $437.77 Million | $62.12 Million | 2.35x | 16.53x |
| 2022 | $1.24 Billion | $498.99 Million | $91.39 Million | 2.48x | 13.52x |
| 2023 | $2.73 Billion | $644.39 Million | $137.54 Million | 4.23x | 19.83x |
| 2024 | $1.64 Billion | $731.97 Million | $159.52 Million | 2.24x | 10.26x |
| 2025 | $1.18 Billion | $719.89 Million | $98.09 Million | 1.64x | 12.04x |
Competitor Companies of AMPH by Market Capitalization
Companies near Amphastar P in the global market cap rankings as of June 18, 2026.
Key companies related to Amphastar P by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Amphastar P Historical Marketcap From 2015 to 2026
Between 2015 and today, Amphastar P's market cap moved from $627.44 Million to $ 880.09 Million, with a yearly change of 4.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $880.09 Million | -25.47% |
| 2025 | $1.18 Billion | -27.88% |
| 2024 | $1.64 Billion | -39.97% |
| 2023 | $2.73 Billion | +120.74% |
| 2022 | $1.24 Billion | +20.31% |
| 2021 | $1.03 Billion | +15.81% |
| 2020 | $886.71 Million | +4.25% |
| 2019 | $850.55 Million | -3.07% |
| 2018 | $877.45 Million | +3.43% |
| 2017 | $848.35 Million | +4.45% |
| 2016 | $812.19 Million | +29.44% |
| 2015 | $627.44 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Amphastar P was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $854.96 Million USD |
| MoneyControl | $854.96 Million USD |
| MarketWatch | $854.96 Million USD |
| marketcap.company | $854.96 Million USD |
| Reuters | $854.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amphastar P
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mi… Read more